Myra Reed, MD
Adult Medicine · Panama City Beach, FLNPI 1215996434
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $14,253 of the $15,896 with a category attached, or 89.7%. Orthofix Medical, Inc. accounts for 89.7% of it on its own, with 12 other manufacturers making up the rest. Among adult medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $203.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$14K
- Novo Nordisk$583
- Galderma Laboratories, L.p.$412
- Lilly USA, LLC$200
- AbbVie$127
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$94
- plus $228 from 7 others
What the payments were for
- Royalty or licence$14,25390%
- Speaking & faculty fees$1501%
- Food & beverage$1,4939%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 24 | $14,253 |
| Novo Nordisk | 22 | $583 |
| Galderma Laboratories, L.p. | 6 | $412 |
| Lilly USA, LLC | 6 | $200 |
| AbbVie(2 entities) | 3 | $127 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $94 |
| IBSA Pharma Inc. | 3 | $67 |
| AstraZeneca(2 entities) | 3 | $49 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Merck | 1 | $25 |
| Novartis | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NGage$6,872
- NGage Surgical Mesh System$4,474
- Physio-Stim$2,907
- MOUNJARO$120
- RYBELSUS$116
How this compares
$15,896 in reported general payments places this provider in the 95th percentile of 195 adult medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 30 | $40,106 |
| EliquisApixaban | 22 | $19,161 |
| MyrbetriqMirabegron | 12 | $6,697 |
| SynthroidLevothyroxine Sodium | 30 | $2,671 |
| ProgesteroneProgesterone, Micronized | 44 | $1,897 |
| Estradiol (Twice Weekly)Estradiol | 17 | $1,250 |
| Liothyronine Sodium | 19 | $749 |
| Rosuvastatin Calcium | 60 | $709 |
| Ezetimibe | 28 | $647 |
| FenofibrateFenofibrate,micronized | 15 | $622 |
| Levothyroxine Sodium | 49 | $618 |
| Nystatin | 12 | $553 |
| Losartan Potassium | 20 | $398 |
| Metoprolol Succinate | 12 | $393 |
| Valsartan | 13 | $343 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $200 | $40,10630 claims |
| AbbVieSynthroid | $127 | $2,67130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 195 adult medicine providers in Florida.
Other adult medicine in Panama City Beach
- Steven SantiagoMiami$290K
- Tammy DsouzaKissimmee$191K
- Eric SchertzerPlantation$26K
- Ricardo SerranoMerritt Island$20K
- Marlene JarinMiami Beach$18K
- Joshua RycusCoral Springs$13K
- Frederick WeigandDeltona$9K
- Hernando ChongMiami$9K
- Neri FranzonFt Lauderdale$9K
- Luis AlvarezBoca Raton$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.